Wide therapeutic time window for Rho-kinase inhibition therapy in ischemic brain damage in a rat cerebral thrombosis model - PubMed (original) (raw)
Wide therapeutic time window for Rho-kinase inhibition therapy in ischemic brain damage in a rat cerebral thrombosis model
Shin-ichi Satoh et al. Brain Res. 2008.
Abstract
The aim of this study was to investigate the influence of delayed Rho-kinase inhibition with fasudil on second ischemic injury in a rat cerebral thrombosis model. Cerebral ischemia was induced in rats by injecting 150 mug of sodium laurate into the left internal carotid artery on day 1. In the ischemic group, the regional cerebral blood flow (rCBF) was significantly decreased 6.5 h after the injection. Fasudil (3 mg/kg/30 min i.v. infusion) significantly increased rCBF. The viscosity of whole blood was significantly increased 48 h after the injection of sodium laurate. Fasudil (10 mg/kg, i.p.) significantly decreased blood viscosity. To clarify the therapeutic time window of fasudil, rats received their first i.p. administration of fasudil (10 mg/kg) 6 h after an injection of sodium laurate. Administration of fasudil twice daily was continued until day 4. Fasudil prevented the accumulation of neutrophils within the brain as seen from measurements taken on day 3, and improved neuronal functions and reduced the infarction area as seen on day 5. Fasudil and hydroxyfasudil, an active metabolite of fasudil, concentration-dependently inhibited phosphorylation of myosin binding subunit of myosin phosphatase in neutrophils. The present results indicate that inhibition of Rho-kinase activation with fasudil is effective for the treatment of ischemic brain damage with a wide therapeutic time window by improving hemodynamic function and preventing the inflammatory responses. These results suggest that fasudil will be a novel and efficacious approach for the treatment of acute ischemic stroke.
Similar articles
- Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage.
Satoh S, Hitomi A, Ikegaki I, Kawasaki K, Nakazono O, Iwasaki M, Mohri M, Asano T. Satoh S, et al. Brain Res Bull. 2010 Jan 15;81(1):191-5. doi: 10.1016/j.brainresbull.2009.08.021. Brain Res Bull. 2010. PMID: 19723568 - Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage.
Satoh S, Utsunomiya T, Tsurui K, Kobayashi T, Ikegaki I, Sasaki Y, Asano T. Satoh S, et al. Life Sci. 2001 Aug 10;69(12):1441-53. doi: 10.1016/s0024-3205(01)01229-2. Life Sci. 2001. PMID: 11531167 - Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons.
Yamashita K, Kotani Y, Nakajima Y, Shimazawa M, Yoshimura S, Nakashima S, Iwama T, Hara H. Yamashita K, et al. Brain Res. 2007 Jun 18;1154:215-24. doi: 10.1016/j.brainres.2007.04.013. Epub 2007 Apr 11. Brain Res. 2007. PMID: 17482584 - Pleiotropic effects of the rho-kinase inhibitor fasudil after subarachnoid hemorrhage: a review of preclinical and clinical studies.
Satoh S, Ikegaki I, Kawasaki K, Asano T, Shibuya M. Satoh S, et al. Curr Vasc Pharmacol. 2014;12(5):758-65. doi: 10.2174/1570161112666140613115813. Curr Vasc Pharmacol. 2014. PMID: 24923440 Review. - [Development of drug delivery system for intrathecal administration and its therapeutic effect on cerebral vasospasm and ischemia].
Ishida T. Ishida T. Yakugaku Zasshi. 2004 Aug;124(8):541-7. doi: 10.1248/yakushi.124.541. Yakugaku Zasshi. 2004. PMID: 15297723 Review. Japanese.
Cited by
- Fasudil may alleviate alcohol-induced astrocyte damage by modifying lipid metabolism, as determined by metabonomics analysis.
Zhao H, Li X, Zheng Y, Zhu X, Qi X, Huang X, Bai S, Wu C, Sun G. Zhao H, et al. PeerJ. 2023 Jun 6;11:e15494. doi: 10.7717/peerj.15494. eCollection 2023. PeerJ. 2023. PMID: 37304877 Free PMC article. - Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury.
Kimura T, Horikoshi Y, Kuriyagawa C, Niiyama Y. Kimura T, et al. Int J Mol Sci. 2021 Oct 26;22(21):11573. doi: 10.3390/ijms222111573. Int J Mol Sci. 2021. PMID: 34769004 Free PMC article. Review. - Lysophospholipids and Their G-Coupled Protein Signaling in Alzheimer's Disease: From Physiological Performance to Pathological Impairment.
Hao Y, Guo M, Feng Y, Dong Q, Cui M. Hao Y, et al. Front Mol Neurosci. 2020 Apr 15;13:58. doi: 10.3389/fnmol.2020.00058. eCollection 2020. Front Mol Neurosci. 2020. PMID: 32351364 Free PMC article. - Fasudil may induce the differentiation of bone marrow mesenchymal stem cells into neuron‑like cells via the Wnt/β‑catenin pathway.
Hu Y, Li X, Huang G, Wang J, Lu W. Hu Y, et al. Mol Med Rep. 2019 Apr;19(4):3095-3104. doi: 10.3892/mmr.2019.9978. Epub 2019 Feb 22. Mol Med Rep. 2019. PMID: 30816472 Free PMC article. - Matrine Treatment Blocks NogoA-Induced Neural Inhibitory Signaling Pathway in Ongoing Experimental Autoimmune Encephalomyelitis.
Kan QC, Zhang HJ, Zhang Y, Li X, Xu YM, Thome R, Zhang ML, Liu N, Chu YJ, Zhang GX, Zhu L. Kan QC, et al. Mol Neurobiol. 2017 Dec;54(10):8404-8418. doi: 10.1007/s12035-016-0333-1. Epub 2016 Dec 9. Mol Neurobiol. 2017. PMID: 27933584
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources